We are international
• about myeloma TEXT SIZE   

Order your free publications online
or download the publications order form to fax to the IMF

Sign up for the Myeloma Minute™, the free e-mail newsletter for up-to-the 'minute' information about myeloma.

Publications of the IMF’s International Myeloma Working Group (IMWG)
The IMWG consists of 109 leading myeloma researchers from around the world who collaborate on a broad range of myeloma research projects with a goal to improve myeloma treatment options and diagnostic systems.
Concise Review of the Disease and Treatment Options

The IMF Concise Review of the Disease and Treatment Options is an overview of myeloma, with a discussion of the pathophysiology, clinical features, and treatment options. It is hoped that the information will be helpful to health professionals and patients alike.

Understanding Protein Electrophoresis
Production of a single, monoclonal protein (M-protein) is a characteristic feature of multiple myeloma. The test used to measure the amount of monoclonal protein in the blood or urine is protein electrophoresis.
Early Screening for Monoclonal Gammopathies
Flow chart starting with risk factors and associated symptoms through the laboratory work ups.

Monitoring Patients with M-Proteins
Myeloma Management Guidelines: A Consensus Report from the Scientific Advisors of the IMF
These guidelines encompass both the published literature and expert opinions. Recommendations based upon expert opinions are identified as such. The intent is for the guidelines to be international in scope, plus provide recommendations for both clinical practice and research approaches. This article appeared in The Hematology Journal (2003) 4, 379-398.

The IMF is pleased to bring you CITINGS, a quarterly publication featuring the most up-to-date information on research advances and new therapies for the treatment for multiple myeloma.
IMF Professional Publications Archive